Verastem Oncology
VSTM
#6413
Rank
NZ$1.35 B
Marketcap
NZ$17.93
Share price
-2.26%
Change (1 day)
85.32%
Change (1 year)

Market capitalization of Verastem Oncology (VSTM)

Market cap: NZ$1.35 Billion

As of December 2025 Verastem Oncology has a market cap of NZ$1.35 Billion. This makes Verastem Oncology the world's 6413th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Verastem Oncology from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.35 B361.34%
2024NZ$0.29 B-9.98%
2023NZ$0.32 B144.2%
2022NZ$0.13 B-75.64%
2021NZ$0.54 B9.1%
2020NZ$0.50 B214.4%
2019NZ$0.15 B-56.88%
2018NZ$0.36 B69.23%
2017NZ$0.21 B265.24%
2016NZ$59.81 M-40.42%
2015NZ$0.10 B-68.43%
2014NZ$0.31 B-9.5%
2013NZ$0.35 B61.48%
2012NZ$0.21 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Verastem Oncology was reported to be:

NZ$1.19 Billion
by Nasdaq info icon info icon
NZ$1.35 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Curis
CRIS
NZ$30.21 M-97.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$256.18 B 18,866.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$37.16 B 2,651.74%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$169.15 B 12,422.99%๐Ÿ‡ฌ๐Ÿ‡ง UK